Reduced Beta Nicotinamide Mononucleotide Powder(NMNH)

(1 customer review)

NMNH (Reduced β‑Nicotinamide Mononucleotide) is a natural NAD⁺ precursor found in the human kidney. Compared to NMN or NR, NMNH elevates NAD⁺ levels more rapidly and effectively. It operates through a distinct metabolic pathway independent of NRK and NAMPT. Following NMNH intake, NAD⁺ in whole blood rises quickly and remains elevated, supporting the repair of hypoxic cell damage and reducing TCA cycle–related inflammation.

Key Benefits:

  • Rapidly boosts NAD⁺ levels

  • Repairs hypoxic cell damage

  • Suppresses TCA cycle–associated inflammation

  • Regulates cellular metabolism and supports mitochondrial health

  • Suitable for research or supplement studies

Key attributes

Product Name β‑Nicotinamide Mononucleotide(NMN)
INCI Name Nicotinamide Mononucleotide, Reduced Form
Appearance Light yellow powder
Specification 98%
MF C11H15N2Na2O8P   C11H17N2O8P
CAS No. 108347-85-9
Test Method HPLC
Packaging  1kg/Bag or 25kg/Fiber Drum
Category: Tags: ,

Why Choose Derma Reshine NMNH

  • Own Factory: Full production control ensures quality and stable supply.

  • High Cost-Performance: Stable supply and reasonable pricing, ideal for research and industrial applications.

  • Technical Advantage: Unique crystal form, non-lyophilized, excellent product stability and easy storage.

  • High Purity: ≥98% purity ensures maximum activity and efficacy.

  • Research & Innovation: Science-based, research-oriented, suitable for supplement and development applications.

1 review for Reduced Beta Nicotinamide Mononucleotide Powder(NMNH)

  1. Saw Yen

    The package arrived very fast.the aftersales service has been great too. The price is very reasonable.

Add a review

Your email address will not be published. Required fields are marked *